Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.84 |
| ▸ | POLB | P06746 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.70 |
| ▸ | GAA | P10253 | 8/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | GLA | P06280 | 4/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13091145 | 0.92 | TSHR (1.00) | TSHRPOLBMAPTKDM4EALDH1A1 | |
| SCHEMBL13091095 | 0.91 | TSHR (0.82) | TSHRPOLBMAPTKDM4EALDH1A1 | |
| SCHEMBL13091099 | 0.88 | ALDH1A1 (0.84) | TSHRMAPTKDM4EALDH1A1HSD17B10 | |
| SCHEMBL13091048 | 0.87 | TSHR (0.91) | TSHRPOLBMAPTKDM4EALDH1A1 | |
| SCHEMBL13091151 | 0.85 | SMN1; SMN2 (0.78) | TSHRPOLBMAPTKDM4EALDH1A1 | |
| SCHEMBL13091072 | 0.83 | ALDH1A1 (0.84) | TSHRMAPTKDM4EALDH1A1HSD17B10 | |
| SCHEMBL13091075 | 0.83 | ALDH1A1 (0.84) | MAPTKDM4EALDH1A1HSD17B10GAA | |
| SCHEMBL13091015 | 0.77 | GAA (0.85) | MAPTKDM4EALDH1A1HSD17B10GAA | |
| SCHEMBL13942453 | 0.76 | TSHR (0.52) | TSHRPOLBMAPTKDM4EALDH1A1 | |
| SCHEMBL13091011 | 0.76 | GAA (0.86) | TSHRMAPTKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | BAX, BCL2, BAD | TSHR 4664/4885POLB 2440/4885MAPT 2663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.